# Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer Patients

> **NCT00354978** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 49 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** 5-Fluorouracil
- **DRUG:** Bevacizumab
- **DRUG:** Leucovorin
- **DRUG:** Irinotecan

## Key facts

- **NCT ID:** NCT00354978
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2011-10-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00354978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00354978, "Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer Patients". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00354978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*